HMGB1 and systemic lupus erythematosus: Since HMGB1 itself is implicated in the pathogenesis of SLE, contributing to the generation of anti-DNA antibodies and preventing lymphocyte apoptosis, an intervention that targets the function of HMGB1 might prove to be superior to targeting interferon.